ENTITY
CSL Ltd

CSL Ltd (CSL AU)

120
Analysis
Health CareAustralia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
18 Nov 2018 14:21

Low Tide on Aussie Growth Stocks

Growth isn’t Dead Yet. Value’s outperformance in the past couple of months is relatively small compared to past periods and we think the...

Logo
356 Views
Share
20 Oct 2018 08:35

It’s Not Over Yet, but Lift the Bar on Defence

A Correction and Not the End of the Cycle. In our view, the equity market sell-off in the past few weeks is a correction and a return to more...

Logo
422 Views
Share
30 Sep 2018 06:56

Aussie Equities Month in Review (Sept 2018)

Giving Back Reporting Season Gains. In our view, reporting season was relatively solid, with 8% EPS growth achieved in FY18 and another 8%...

Logo
367 Views
Share
26 Sep 2018 18:37

Aussie Equities Model Portfolio Update

Good outperformance by staying long growth. Our model portfolio has a tilt towards Growth over Value and this has underpinned its solid...

Logo
419 Views
Share
bullishMSCI ACWI Index
07 Sep 2018 20:32

Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index.  In today’s report...

Logo
445 Views
Share
x